|
End-of-day quote
Korea S.E.
2026-10-16
|
5-day change | 1st Jan Change | ||
| 4,705.00 KRW | +11.49% |
|
-13.99% | -31.61% |
| 09-20 | Genome & Company(KOSDAQ:A314130) added to S&P Global BMI Index | CI |
| 08-14 | Genome & Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +11.49% | -13.99% | +38.18% | +21.26% | -31.61% | +67.74% | -28.71% | -74.11% | - | 164M | |
| -6.60% | -10.93% | -7.90% | +9.73% | +59.20% | +45.08% | +60.01% | -0.71% | - | 68.98B | |
| -4.09% | +3.12% | -15.28% | -3.06% | +1.51% | +3.71% | +53.50% | +185.00% | +4,786.50% | 53.15B | |
| +0.03% | +7.21% | +12.43% | +3.89% | +12.31% | +12.52% | +44.46% | -16.32% | +231.87% | 50.83B | |
| -1.53% | +2.70% | -0.71% | +26.80% | +18.41% | +29.72% | +34.13% | +7.42% | +254.54% | 44.61B | |
| -5.97% | -6.22% | -9.17% | -0.68% | +123.43% | +258.21% | +421.57% | +535.57% | - | 40.57B | |
| -1.34% | +4.12% | +6.03% | +16.27% | +21.48% | +16.05% | +112.18% | +2.29% | +1,034.52% | 42.53B | |
| +6.53% | +8.02% | +9.30% | +10.42% | +12.54% | +18.98% | +54.58% | +7.26% | +169.34% | 30.95B | |
| -0.90% | -10.91% | -2.07% | +21.90% | +53.31% | +34.11% | -1.83% | -55.94% | - | 25.44B | |
| -2.76% | -9.54% | -8.47% | -4.20% | -7.87% | -16.53% | -9.55% | -66.41% | - | 22.66B | |
| -1.07% | +6.20% | +16.37% | +31.96% | +23.43% | +20.52% | +10.51% | -12.27% | +122.80% | 22.65B | |
| -2.96% | -4.30% | -21.46% | -10.41% | -44.69% | -41.01% | +283.85% | +265.21% | +608.39% | 21.67B | |
| -1.61% | +1.05% | +0.33% | +14.97% | +10.12% | +18.66% | +160.66% | +232.83% | +1,996.51% | 17.55B | |
| +3.32% | +4.18% | +3.32% | -5.68% | +193.84% | +168.17% | +386.54% | +1,614.31% | +817.72% | 15.42B | |
| -0.95% | +3.96% | +9.60% | +11.76% | +41.98% | +58.71% | +188.50% | +192.02% | +440.66% | 15.57B | |
| -1.14% | +3.38% | +6.51% | +12.93% | +25.42% | +26.55% | +57.62% | -27.90% | +87.27% | 15.4B | |
| -0.60% | -1.74% | -9.06% | -13.30% | - | - | - | - | - | 14.88B | |
| -1.99% | -0.54% | +9.78% | +30.98% | +50.47% | +71.56% | +55.73% | -27.50% | +274.95% | 14.62B | |
| +3.10% | +1.39% | -2.25% | -15.75% | +15.25% | -3.54% | +445.89% | - | - | 13.35B | |
| -2.83% | +3.66% | -2.16% | +0.11% | -6.61% | -9.70% | -30.58% | -38.47% | +120.16% | 13.51B | |
| Average | -0.61% | +1.91% | +1.67% | +7.99% | +30.10% | +41.03% | +121.00% | +151.24% | +841.94% | 27.23B | |
| Weighted average by Cap. | -1.96% | +2.18% | -1.21% | +8.18% | +33.45% | +41.93% | +112.17% | +124.89% | +1,127.71% |
- Stock Market
- Stocks
- A314130 Stock
- Sector Genome & Company
Select your edition
All financial news and data tailored to specific country editions
